연구동향
이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.
129편 검색→119편 판독→48편 선별 (관련도 0.5 이상)
질문과 PubMed 검색식 보기
질문: Prevalence and risk factors of monoclonal gammopathy of undetermined significance in older adults
Prevalence and risk factors of monoclonal gammopathy of undetermined significance in older adults출판 연도
선별된 48편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.
주제별 논문
주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.
01samples · electrophoresis20편
- 0.95
Park HK, Lee KR, Kim YJ et al. · American journal of hematology · 2011
- 0.94
Prevalence of monoclonal gammopathy of undetermined significance in Thailand
Watanaboonyongcharoen P, Nakorn TN, Rojnuckarin P et al. · International journal of hematology · 2012
- 0.94
Landgren O, Graubard BI, Katzmann JA et al. · Leukemia · 2014
- 0.92
Dispenzieri A, Katzmann JA, Kyle RA et al. · Lancet (London, England) · 2010
- 0.91
Schmidt B, Debold E, Frank M et al. · Annals of hematology · 2019
- 0.91
Oliota AFR, Borsa MP, da Cunha Junior AD et al. · Cancer epidemiology · 2026
- 0.91
Landgren O, Kyle RA, Hoppin JA et al. · Blood · 2009
- 0.90
Fujimura K, Sugiyama A, Akita T et al. · International journal of hematology · 2021
- 0.88
Therneau TM, Kyle RA, Melton LJ3 et al. · Mayo Clinic proceedings · 2012
- 0.87
Dietary intake is associated with risk of multiple myeloma and its precursor disease
Thordardottir M, Lindqvist EK, Lund SH et al. · PloS one · 2018
- 0.86
Vachon CM, Kyle RA, Therneau TM et al. · Blood · 2009
- 0.83
Lee JY, Jung EJ, Kwon S et al. · Haematologica · 2026
- 0.83
Jeong TD, Lee W, Chun S et al. · BioMed research international · 2014
- 0.83
Prevalence of Monoclonal Gammopathy of Undetermined Significance in India-A Hospital-based Study
Gupta R, Dahiya M, Kumar L et al. · Clinical lymphoma, myeloma & leukemia · 2018
- 0.83
Landgren O, Zeig-Owens R, Giricz O et al. · JAMA oncology · 2018
- 0.71
Zwick C, Held G, Auth M et al. · International journal of cancer · 2014
- 0.69
Greenberg AJ, Lee AM, Serie DJ et al. · Leukemia · 2013
- 0.68
Katzmann JA, Clark R, Kyle RA et al. · Leukemia · 2013
- 0.61
Landgren O, Hofmann JN, McShane CM et al. · JAMA oncology · 2019
- 0.56
Abnormal Plasma Cell Disorders in Refinery Waste Workers
Ledda C, Loreto C, Filetti V et al. · Journal of clinical medicine · 2018
02lymphoma · relative15편
- 0.87
Risk of MGUS in relatives of multiple myeloma cases by clinical and tumor characteristics
Clay-Gilmour AI, Kumar S, Rajkumar SV et al. · Leukemia · 2019
- 0.86
Rognvaldsson S, Thorsteinsdottir S, Syriopoulou E et al. · Haematologica · 2024
- 0.71
Gregersen H, Mellemkjaer L, Ibsen JS et al. · Haematologica · 2001
- 0.66
Kristinsson SY, Bjorkholm M, Goldin LR et al. · Blood · 2008
- 0.64
A long-term study of prognosis in monoclonal gammopathy of undetermined significance
Kyle RA, Therneau TM, Rajkumar SV et al. · The New England journal of medicine · 2002
- 0.62
Kristinsson SY, Bjorkholm M, Goldin LR et al. · International journal of cancer · 2009
- 0.62
Risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance
Pasqualetti P, Casale R · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 1997
- 0.61
Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance
Kyle RA, Larson DR, Therneau TM et al. · The New England journal of medicine · 2018
- 0.58
Long-term follow-up of a population based cohort with monoclonal proteinaemia
Schaar CG, le Cessie S, Snijder S et al. · British journal of haematology · 2009
- 0.56
Landgren O, Kristinsson SY, Goldin LR et al. · Blood · 2009
- 0.55
Za T, De Stefano V, Rossi E et al. · British journal of haematology · 2013
- 0.53
van de Poel MH, Coebergh JW, Hillen HF · British journal of haematology · 1995
- 0.53
Alfano G, Fontana F, Colaci E et al. · Transplantation · 2017
- 0.52
Familial paraproteinemia: hyper-responsive B-cells as endophenotype
Ogmundsdottir HM, Steingrimsdottir H, Haraldsdottir V · Clinical lymphoma, myeloma & leukemia · 2011
- 0.51
Galioto A, Morando F, Rosi S et al. · Transplant international : official journal of the European Society for Organ Transplantation · 2012
03veterans · race9편
- 0.94
Lee DJ, Chen WC, Bertamini L et al. · EClinicalMedicine · 2026
- 0.93
Landgren O, Rajkumar SV, Pfeiffer RM et al. · Blood · 2010
- 0.90
Landgren O, Shim YK, Michalek J et al. · JAMA oncology · 2015
- 0.89
Landgren O, Gridley G, Turesson I et al. · Blood · 2006
- 0.88
Iwanaga M, Tagawa M, Tsukasaki K et al. · Blood · 2009
- 0.76
Brown LM, Gridley G, Check D et al. · Blood · 2008
- 0.64
Cumulative Excess Body Mass Index and MGUS Progression to Myeloma
Liu L, Grandhi N, Wang M et al. · JAMA network open · 2025
- 0.57
Association and Prognostic Significance of Comorbidities in Individuals With MGUS
Bawek S, Nassour N, Alharbi M et al. · Clinical lymphoma, myeloma & leukemia · 2026
- 0.54
Chang SH, Luo S, O'Brian KK et al. · The Lancet. Haematology · 2015
04disease · therapy4편
- 0.90
Atkin C, Reddy-Kolanu V, Drayson MT et al. · British journal of haematology · 2020
- 0.89
Hallsson S, Gunnarsdottir I, Thordardottir M et al. · Blood cancer journal · 2026
- 0.71
Caviglia GP, Sciacca C, Abate ML et al. · Journal of gastroenterology and hepatology · 2015
- 0.71
Kumar S, Larson DR, Dispenzieri A et al. · Blood cancer journal · 2019